Category: CDMO

The Massive Future of Pharma Contract Manufacturing Beyond 2020

Reading Time: 7 minutes Written By: Shuchi Nahar | Shuchi’s Blog | Linkedin Profile Contract Manufacturing (CDMO) Industry Insight The global pharmaceutical contract manufacturing & contract research market size was valued at over USD 123.1 billion in 2016. Cost-saving and time-saving benefits associated with the implementation of outsourcing is responsible for driving industrial growth. Companies are investing in infrastructure, personnel, and technology in order […]

Neuland Labs Company Snapshot

Reading Time: 4 minutes Written By: Shuchi.P.Nahar | Twitter Handle: @shuchi_nahar Neuland is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs. The Company operates in the market using two main business models – Generic Drug Substances (GDS) where they cater to the needs of the Generic players and Custom […]

Evolution in Biosimilars, Opportunities and Market size Growth Ahead

Reading Time: 3 minutes Figure 4: Evolution of Biosimilars and rising approvals Source: Bill of Health – Harvard Law Biosimilars have a bright future if additional work is done to be attractive to prescribers and payers. Trends show that providers are already aware of biosimilars and are interested in learning more about them.Similarly, payers are showing a desire to […]

What is so attractive about CDMO’s in Pharmaceutical Companies?

Reading Time: 6 minutes CDMO’s to be considered as next stepping stone for Pharma Companies… SHUCHI.P.NAHAR Link: In recent years, pharmaceutical outsourcing has grown in popularity amongst drug developers across the industry. Companies are increasingly outsourcing to contract development and manufacturing organisations (CDMOs) due to the benefits outside expertise can bring to their business. So, what are the […]

Pharma Sector by Aditya Khemka

Reading Time: 4 minutes SHUCHI.P.NAHAR Pharma business is divided into two models: Domestic  Export  Domestic Model This model is typically like a FMCG business. In domestic markets those pharma companies who have branding power will have a good pricing power among other competitors. In pharma, doctors are the main customer of the product and the patient is just a […]

Understanding Pharma Growth from various important corners

Reading Time: 9 minutes “Practitioners’ Insights: Understanding Pharma” Shuchi.P.Nahar India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies over 50% of global demand for various vaccines, 40% of generic demand in the US and 25 % of all medicine in UK. India enjoys an important position in the global pharmaceuticals sector. The country also has […]

Back To Top